Serotonin Syndrome: How to Recognize It and What to Do

Serotonin syndrome is a drug reaction caused by too much serotonin activity in the nervous system. It can range from mild and self-resolving to life-threatening. The cardinal sign is clonus: rhythmic, involuntary muscle contractions that a clinician can trigger by flexing your foot or examining your eyes. At its worst, serotonin syndrome causes temperatures above 41°C (106°F), extreme muscle rigidity, organ failure, and death. It is not rare in the festival and rave context, and knowing how to recognize it early is the difference between a hospital visit and an ICU admission.

Quick answers

How do I know if I have serotonin syndrome? The most specific sign is clonus, rhythmic muscle contractions you didn’t cause. Other early signs include muscle twitching, hyperreflexia (exaggerated reflexes), heavy sweating, agitation, and a racing heart. You don’t need all of these. If someone has taken a serotonergic drug and has clonus plus agitation or sweating, that meets the clinical diagnostic threshold.

Can MDMA cause serotonin syndrome? Yes, especially in combination with other drugs. MDMA floods the synapse with serotonin by reversing the serotonin transporter. On its own, this rarely produces full serotonin syndrome in otherwise healthy people. In combination with an SSRI, SNRI, MAOI, lithium, tramadol, or St. John’s Wort, the risk rises substantially.

What about MDMA and SSRIs together? SSRIs partially block MDMA’s primary mechanism, so they don’t simply add serotonin on top of MDMA’s serotonin. The absolute risk from this combination alone is lower than commonly assumed. The danger increases if the person takes more MDMA to compensate for blunted effects, or if additional serotonergic substances are present. See our MDMA and SSRI interaction guide for the full pharmacology.

What does clonus feel like? People describe it as an ankle “beating” or pulsing rhythmically when you flex it, eyes that seem to jitter sideways on their own, or legs that won’t stop moving. It is not the same as jaw clenching or general restlessness. Spontaneous clonus, occurring without any external trigger, is a red flag for severe toxicity.

Is serotonin syndrome the same as overheating? No, though both involve high body temperature. The differentiating features are the muscle findings: overheating does not cause clonus or exaggerated reflexes. See the comparison section below.

The symptoms: what serotonin syndrome actually looks like

Clinicians use the Hunter Serotonin Toxicity Criteria to diagnose serotonin syndrome. Validated against toxicology case records, these criteria outperform the older Sternbach criteria. (PMID 15858183) A person meets criteria if they have taken a serotonergic agent and have at least one of the following:

• Spontaneous clonus
• Inducible clonus (triggered by flexing the ankle) plus agitation or diaphoresis (heavy sweating)
• Ocular clonus (the eyes drift and beat rhythmically) plus agitation or diaphoresis
• Tremor plus hyperreflexia
• Muscle rigidity plus a temperature above 38°C (100.4°F) plus clonus

The symptoms cluster into three categories, though all three don’t need to be present for a diagnosis.

Neuromuscular: clonus, hyperreflexia (reflexes much stronger than normal), myoclonus (brief involuntary muscle jerks), tremor, and rigidity in severe cases. These are the most specific signs. Other drug reactions and medical emergencies don’t typically produce clonus.

Autonomic instability: hyperthermia, rapid heart rate, high blood pressure, heavy sweating, dilated pupils, diarrhea. These signs overlap with other emergencies, which is why the neuromuscular findings are what distinguish serotonin syndrome.

Altered mental status: agitation, anxiety, confusion, disorientation. These are the least specific signs on their own but contribute to the overall picture.

Severity spectrum:

Mild cases involve tremor, tachycardia, sweating, and dilated pupils. These often resolve within 24 hours once the offending drug is removed.

Moderate cases involve temperatures up to 40°C (104°F), significant agitation, clonus, and hyperreflexia. These require medical attention.

Severe cases involve temperatures above 41°C (106°F), extreme muscle rigidity, rhabdomyolysis (muscle breakdown that can damage the kidneys), renal failure, and can be fatal. Anyone at this stage needs an ICU.

How to tell it apart from overheating or a bad trip

Serotonin syndrome vs. heat stroke: Both involve high temperature, confusion, and cardiovascular stress. Heat stroke does not cause clonus, hyperreflexia, or muscle jerking. A person who is simply hot and dehydrated will not have a pulsing ankle when you flex their foot. The presence of neuromuscular signs points away from heat illness and toward serotonin toxicity.

Serotonin syndrome vs. neuroleptic malignant syndrome (NMS): NMS is caused by antipsychotic medications and is sometimes confused with serotonin syndrome because both involve hyperthermia and muscle findings. The differences are clinically important:

• NMS develops slowly, over days. Serotonin syndrome develops over hours.
• NMS produces “lead-pipe” rigidity and slowed or absent reflexes (bradyreflexia). Serotonin syndrome produces hyperreflexia and clonus.
• Clonus is a key differentiator: NMS does not cause it, serotonin syndrome does.
• NMS is associated with antipsychotic exposure; serotonin syndrome is associated with serotonergic drug combinations.

Serotonin syndrome vs. anticholinergic toxidrome: Anticholinergic poisoning (from diphenhydramine overdose, for example, or certain plants) also causes agitation, dilated pupils, fast heart rate, and elevated temperature. The key difference is the skin: anticholinergic toxidrome produces flushed, dry skin and absent bowel sounds (“hot as a hare, dry as a bone”). Serotonin syndrome produces heavy sweating (diaphoresis) and active, often hyperactive bowel sounds.

Which drug combinations cause it

Not all combinations carry equal risk. Here is a ranked overview.

Highest risk:

MDMA plus MAOIs. This is the most dangerous combination and has a documented fatality record. MAO enzymes normally break down serotonin after it’s released. When an MAOI is present, serotonin released by MDMA accumulates without being cleared. MAOIs include phenelzine (Nardil), tranylcypromine (Parnate), selegiline (Emsam), and moclobemide. The antibiotic linezolid also has MAOI activity and is an underrecognized risk. Multiple fatal cases involving MDMA plus moclobemide were reported to the Victorian State Coroner. If you take an MAOI, MDMA is an absolute contraindication.

Significant risk:

MDMA plus SSRIs or SNRIs. SSRIs blunt MDMA’s effects rather than amplifying them, so serotonin syndrome from this combination alone is less common than feared. The elevated risk comes when users take escalating doses of MDMA trying to overcome the SSRI blockade, adding far more serotonergic load than intended, or when additional substances are present.

MDMA plus lithium. Lithium increases serotonin release. Combining it with MDMA, which also increases serotonin release, amplifies the overall serotonergic burden.

Moderate or additive risk:

MDMA plus tramadol. Tramadol is a weak serotonin reuptake inhibitor in addition to its opioid activity. It raises serotonin levels modestly but adds to the total serotonergic load.

MDMA plus St. John’s Wort. St. John’s Wort inhibits serotonin reuptake. Multiple case reports exist of serotonin syndrome symptoms with this combination. It is widely considered a “natural” supplement, but pharmacologically it behaves like a mild SSRI.

Triptans (migraine medications) plus SSRIs or MDMA. The FDA issued a 2006 advisory about triptans plus SSRIs. The absolute risk is lower than the warning implied, but triptans are 5-HT1B/1D agonists and add serotonergic activity. If you’re taking a triptan and also use MDMA or other serotonergic substances, the combined load is higher.

The SSRI problem: stopping for the weekend doesn’t work

One of the most common and dangerous misconceptions is that you can stop taking an SSRI for a day or two before using MDMA and eliminate the interaction. For most SSRIs, this is incorrect. For fluoxetine, it is dramatically incorrect.

Fluoxetine’s active metabolite, norfluoxetine, has a half-life of 4 to 16 days. Stopping fluoxetine on Thursday before a Saturday event leaves the drug essentially fully active in your system. The serotonin transporter is still blocked. The pharmacokinetic interaction persists.

Human evidence: a controlled study by Farre et al. (2007) in healthy volunteers given SSRI pretreatment before MDMA confirmed that SSRIs substantially blunt MDMA’s subjective effects while the pharmacokinetic interaction, including elevated MDMA plasma concentrations due to CYP2D6 inhibition, remains intact. (PMID 17392394) The experience is worse and the pharmacological exposure is not eliminated.

This matters for serotonin syndrome risk in a specific way. If a person believes their SSRI is “out of their system” and takes MDMA, they may escalate the dose when effects feel blunted, not realizing the SSRI is still pharmacologically active. The result is a higher MDMA dose with persistent serotonin transporter blockade and elevated MDMA plasma levels. That is a higher-risk scenario than simply using MDMA, not a safer one.

For a detailed breakdown of the fluoxetine half-life issue and all SSRI-MDMA interactions, see our MDMA and SSRI interaction guide.

What to do if someone might have serotonin syndrome

Call 911 (or your country’s emergency number) if any of the following are present:

• Temperature above 39°C (102°F)
• Visible muscle twitching or a pulsing/beating ankle when flexed
• Significant confusion or agitation
• Rapid or irregular heart rate
• The person is getting worse

While waiting for help:

Remove or stop any serotonergic substances if possible.

Cool the person actively if they are hot: ice packs to the neck, armpits, and groin; cool water on the skin. Do not give Tylenol (acetaminophen) or ibuprofen for the fever. Serotonin syndrome hyperthermia is caused by uncontrolled muscle activity, not by the normal fever mechanism (prostaglandins). Antipyretics have no effect on this type of temperature elevation.

Benzodiazepines (diazepam, lorazepam) are the first-line medical treatment for agitation, muscle overactivity, and autonomic instability in serotonin syndrome. If a prescriber or emergency clinician is available, these are appropriate. In a festival first-aid context, this means getting the person to a medical tent quickly.

Cyproheptadine, a 5-HT2A antagonist (meaning it blocks the receptor that serotonin binds to), is used as an antidote in moderate cases. It is given by mouth or nasogastric tube, typically 12 mg initially then 2 mg every two hours. This is a hospital-administered treatment, not something you can provide in the field, but knowing it exists is useful context.

What not to do:

Do not give antipsychotics. Older antipsychotics are sometimes used empirically for agitation, but they do not provide adequate 5-HT2 receptor blockade for serotonin syndrome and carry QTc interval prolongation risk.

Do not leave the person alone if they are symptomatic. Serotonin syndrome can deteriorate rapidly.

If you’re trying to assess a specific drug combination before using, see our drug interaction checker. For a full overview of MDMA risks, dosing, and harm reduction strategies, see our MDMA harm reduction guide.

Sources:

Boyer EW, Shannon M. “The serotonin syndrome.” N Engl J Med. 2005;352(11):1112-20. PMID 15858183

Farre M, et al. “Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy, MDMA) and paroxetine: pharmacological effects and pharmacokinetics.” J Pharmacol Exp Ther. 2007;323(3):954-62. PMID 17392394